zadnja posodobitev :
22/08/2024
Infostab
Seznami
Seznami
Poiščite združljivosti
Tabela združljivosti Y-strani
Viri
raziskovalne skupine
valistab
poster
Povezave
sponzorji
Avtor
Navodilo za uporabo
Newsletter
Caffeine citrate
Kemična formula
Lastniško ime
Sestava pomožnih snovi je med paralelami lahko različna
Cafcit
Združene države Amerike
Cafeina 25% Bioquim
Argentina
Cafeina citrato
Španija
Cafeina Fada
Argentina
Cafeine citrate Biomed
nova Zelandija
Cafeine Sterop
Belgija
Cafeinnova
Kolumbija
Caffeinospire
Egipt
Cafirate
Indija
Citrate de caféine Cooper
Francija
Peyona oral y para perfusion
Španija
Peyona oral/parenteral
Nemčija, Romunija, Turčija
Viri : Caffeine citrate
Tip
objava
43
časopis
Fraser BD, Berod T, Whitney HAK.
Stability of caffeine citrate injection in polypropylene syringes at room temperature.
Am J Health-Syst Pharm 1997 ; 54: 1106-1108.
318
časopis
Donnelly RF, Tirona RG.
Stability of citrated caffeine injectable solution in glass vials.
Am J Hosp Pharm 1994 ; 51: 512-514.
691
časopis
Nahata MC, Zingarelli JR, Durell DE.
Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions.
J Clin Pharm Ther 1989 ; 14: 53-55.
1802
časopis
Bell MS, Nolt DH.
Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
Am J Health-Syst Pharm 2003 ; 60: 193-194.
2087
časopis
Ferreira E, Forest JM, Hildgen P.
Compatibility of dimenhydrinate injectable by Y administration.
Pharmactuel 2004 ; 37: 17-20.
3379
časopis
Fox L.M, Wilder A.G, Foushee J.A.
Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
Am J Health-Syst Pharm 2013 ;70:520-524.
3644
Traduction Laboratorij
Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3976
časopis
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4319
časopis
Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4389
časopis
Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4419
časopis
Holt R.J, Siegert S.W.K, Krishna A.
Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161.
4543
časopis
Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4603
časopis
Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4742
časopis
Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.
Mentions Légales